CN103505607A - Traditional Chinese medicine composition used for treating aplastic anemia - Google Patents
Traditional Chinese medicine composition used for treating aplastic anemia Download PDFInfo
- Publication number
- CN103505607A CN103505607A CN201310405830.8A CN201310405830A CN103505607A CN 103505607 A CN103505607 A CN 103505607A CN 201310405830 A CN201310405830 A CN 201310405830A CN 103505607 A CN103505607 A CN 103505607A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine composition
- root
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition used for treating aplastic anemia. The composition is composed of the raw materials of, by weight: 10-12 parts of pilose asiabell root, 4-6 parts of common jujube, 2-4 parts of Mongolian milkvetch root, 5-7 parts of ligusticum, 2-4 parts of prepared rehmannia root, 7-9 parts of Szechwan lovage rhizome, 10-12 parts of medlar, 3-5 parts of largehead atractylodes rhizome, 2-4 parts of tuber fleeceflower root, 5-7 parts of turtle shell, 3-5 parts of epimedium, 2-4 parts of ass-hide gelatin, 5-7 parts of dried human placenta, 1-3 parts of suberect spatholobus stem, 3-5 parts of kadsura root-bark, 5-7 parts of snakegourd root, 2-4 parts of cuttlebone, 6-8 parts of kalimeris indica, 3-5 parts of fragrant plantain lily, 1-3 parts of Japanese raspberry root, 1-3 parts of jatamana valeriana rhizome, and 8-10 parts of lotus seedpod. The traditional Chinese medicine composition is provided with a traditional Chinese medical science theory. The medicine materials are formulated such that qi-benefiting, yin-nourishing, heat-clearing, blood-cooling, stasis-removing, bleeding-stopping, spleen-invigorating, and stomach-nourishing functions are provided. With the medicine composition, bone marrow hematopoietic function can be effectively stimulated, and immunity can be regulated. The medicine composition has good clinical treatment effect in treating aplastic anemia, and has the advantages of low cost, good treatment effect, and reoccurrence prevention.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of aplastic anemia, belong to the field of Chinese medicines.
Background technology
Aplastic anemia belongs to Chinese medicine asthenia symptom, blood disorder scope, and Chinese medicine thinks that generation and the heart of this disease, liver,spleen,kidney internal organs are relevant, is divided into substantially deficiency of both the heart and spleen, deficiency of both QI and blood, hepatic and renal YIN deficiency, deficiency-fire produced in the interior; Western medical treatment is mainly symptomatic treatment, immunosuppressant therapy at present, has erious adverse reaction, and immunosuppressant therapy causes patient's resistance to decline, and easily causes some complication; The cure rate of western medical treatment is low, and easily recurrence after curing, and adopt western medical treatment larger to the damage of human body, and the course for the treatment of is longer.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition for the treatment of aplastic anemia.
The present invention adopts following technical scheme:
The Chinese medicine composition for the treatment of aplastic anemia, the weight portion of its constitutive material is: Radix Codonopsis 10-12, Fructus Jujubae 4-6, Radix Astragali 2-4, Radix Angelicae Sinensis 5-7, Radix Rehmanniae Preparata 2-4, Rhizoma Chuanxiong 7-9, Fructus Lycii 10-12, Rhizoma Atractylodis Macrocephalae 3-5, Radix Polygoni Multiflori 2-4, Carapax Trionycis 5-7, Herba Epimedii 3-5, Colla Corii Asini 2-4, Placenta Hominis 5-7, Caulis Spatholobi 1-3, Cortex cercis chinensis 3-5, Radix Trichosanthis 5-7, Endoconcha Sepiae 2-4, Herba Kalimeridis 6-8, Flos Hostae Plantagineae 3-5, Radix Rubi parvifolii 1-3, Rhizoma valerianae latifoliae 1-3 and lotus receptacle 8-10.
The Chinese medicine composition for the treatment of aplastic anemia, the weight portion of its constitutive material is: Radix Codonopsis 11, Fructus Jujubae 5, the Radix Astragali 3, Radix Angelicae Sinensis 6, Radix Rehmanniae Preparata 3, Rhizoma Chuanxiong 8, Fructus Lycii 11, the Rhizoma Atractylodis Macrocephalae 4, Radix Polygoni Multiflori 3, Carapax Trionycis 6, Herba Epimedii 4, Colla Corii Asini 3, Placenta Hominis 6, Caulis Spatholobi 2, Cortex cercis chinensis 4, Radix Trichosanthis 6, Endoconcha Sepiae 3, Herba Kalimeridis 7, Flos Hostae Plantagineae 4, Radix Rubi parvifolii 2, Rhizoma valerianae latifoliae 2 and lotus receptacle 9.
Consumption and usage: take decoction of the present invention, every day potion.
Beneficial effect of the present invention:
The present invention, according to theory of Chinese medical science, has benefiting qi and nourishing yin, clearing away heat and cooling blood, removing stasis to stop bleeding by each medicine compatibility, the effect of strengthening the spleen and nourishing the stomach, effective stimulus hemopoietic function of bone marrow, regulates immunity, and treatment aplastic anemia has good clinical efficacy, and with low cost, good effect, is difficult for recurrence.
The specific embodiment
Embodiment 1: the Chinese medicine composition for the treatment of aplastic anemia, the weight portion of its constitutive material (g) is: Radix Codonopsis 11, Fructus Jujubae 5, the Radix Astragali 3, Radix Angelicae Sinensis 6, Radix Rehmanniae Preparata 3, Rhizoma Chuanxiong 8, Fructus Lycii 11, the Rhizoma Atractylodis Macrocephalae 4, Radix Polygoni Multiflori 3, Carapax Trionycis 6, Herba Epimedii 4, Colla Corii Asini 3, Placenta Hominis 6, Caulis Spatholobi 2, Cortex cercis chinensis 4, Radix Trichosanthis 6, Endoconcha Sepiae 3, Herba Kalimeridis 7, Flos Hostae Plantagineae 4, Radix Rubi parvifolii 2, Rhizoma valerianae latifoliae 2 and lotus receptacle 9.
Consumption and usage: take decoction of the present invention, every day potion.
Model case:
Case 1: honest and just certain, man, 72 years old, suffers from aplastic anemia 5 years, with green around the gills, body, feel weak, dizzy, cardiopalmus and the symptom such as breathe hard, take 20 doses, Chinese medicine of the present invention, shortness of breath and palpitation alleviates, and can fall asleep night, it is strong that body is felt, continues to take 10 doses, and ill symptoms disappears completely.
Case 2: side certain, man, 39 years old, suffers from aplastic anemia, pale complexion, shortness of breath and palpitation, dizzy insomnia, pale tongue, takes Chinese medicine composition of the present invention, every day potion, take after one week, without shortness of breath and palpitation phenomenon, continue to take after 10 doses, all diseases disappear, recovery from illness.
Case 3: Shen, man, 65 years old, suffers from aplastic anemia more than 3 years, shortness of breath and palpitation, dizzy insomnia, and with tired unable, the appetite of pale complexion, whole body, decline, take Chinese medicine composition of the present invention, every day potion, take after one week, spirit takes a turn for the better, and can pacify night and sleep, continue to take after 15 doses, all diseases disappear, and recovery from illness, follows up a case by regular visits to after half a year and have no recurrence.
Claims (2)
1. treat a Chinese medicine composition for aplastic anemia, it is characterized in that the weight portion of its constitutive material is: Radix Codonopsis 10-12, Fructus Jujubae 4-6, Radix Astragali 2-4, Radix Angelicae Sinensis 5-7, Radix Rehmanniae Preparata 2-4, Rhizoma Chuanxiong 7-9, Fructus Lycii 10-12, Rhizoma Atractylodis Macrocephalae 3-5, Radix Polygoni Multiflori 2-4, Carapax Trionycis 5-7, Herba Epimedii 3-5, Colla Corii Asini 2-4, Placenta Hominis 5-7, Caulis Spatholobi 1-3, Cortex cercis chinensis 3-5, Radix Trichosanthis 5-7, Endoconcha Sepiae 2-4, Herba Kalimeridis 6-8, Flos Hostae Plantagineae 3-5, Radix Rubi parvifolii 1-3, Rhizoma valerianae latifoliae 1-3 and lotus receptacle 8-10.
2. the Chinese medicine composition for the treatment of aplastic anemia according to claim 1, is characterized in that the weight portion of its constitutive material is: Radix Codonopsis 11, Fructus Jujubae 5, the Radix Astragali 3, Radix Angelicae Sinensis 6, Radix Rehmanniae Preparata 3, Rhizoma Chuanxiong 8, Fructus Lycii 11, the Rhizoma Atractylodis Macrocephalae 4, Radix Polygoni Multiflori 3, Carapax Trionycis 6, Herba Epimedii 4, Colla Corii Asini 3, Placenta Hominis 6, Caulis Spatholobi 2, Cortex cercis chinensis 4, Radix Trichosanthis 6, Endoconcha Sepiae 3, Herba Kalimeridis 7, Flos Hostae Plantagineae 4, Radix Rubi parvifolii 2, Rhizoma valerianae latifoliae 2 and lotus receptacle 9.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310405830.8A CN103505607A (en) | 2013-09-09 | 2013-09-09 | Traditional Chinese medicine composition used for treating aplastic anemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310405830.8A CN103505607A (en) | 2013-09-09 | 2013-09-09 | Traditional Chinese medicine composition used for treating aplastic anemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103505607A true CN103505607A (en) | 2014-01-15 |
Family
ID=49889380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310405830.8A Pending CN103505607A (en) | 2013-09-09 | 2013-09-09 | Traditional Chinese medicine composition used for treating aplastic anemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103505607A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104225264A (en) * | 2014-08-26 | 2014-12-24 | 张琦 | Traditional Chinese medicine decoction for treating aplastic anemia |
| CN104491519A (en) * | 2014-12-08 | 2015-04-08 | 吕凤荣 | Yin-nourishing and qi-tonifying preparation for aplastic anemia due to dual depletion of qi and blood and preparation method |
| CN106581275A (en) * | 2017-01-04 | 2017-04-26 | 钱建荣 | Traditional Chinese medicinal composition for treating qi-blood deficiency induced aplastic anemia |
-
2013
- 2013-09-09 CN CN201310405830.8A patent/CN103505607A/en active Pending
Non-Patent Citations (3)
| Title |
|---|
| 侯江红等: "再生障碍性贫血中药治疗的微观研究进展", 《中原医刊》 * |
| 李芮等: "再生障碍性贫血辨证与辨病治疗的机制", 《山东中医杂志》 * |
| 王树庆: "辨证治疗再生障碍性贫血61例", 《山东中医杂志》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104225264A (en) * | 2014-08-26 | 2014-12-24 | 张琦 | Traditional Chinese medicine decoction for treating aplastic anemia |
| CN104491519A (en) * | 2014-12-08 | 2015-04-08 | 吕凤荣 | Yin-nourishing and qi-tonifying preparation for aplastic anemia due to dual depletion of qi and blood and preparation method |
| CN106581275A (en) * | 2017-01-04 | 2017-04-26 | 钱建荣 | Traditional Chinese medicinal composition for treating qi-blood deficiency induced aplastic anemia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102579945A (en) | Traditional Chinese medicinal composition for treating sicca syndrome | |
| CN101152535A (en) | Traditional Chinese medicine for treating subacute thyroiditis | |
| CN101130005A (en) | Traditional Chinese medicine for treating depression and insomnia after liver and cerebral apoplexy | |
| CN101757427A (en) | Heart tonifying and tranquilizing pill | |
| CN101703742B (en) | Preparation method of granules for treating acne caused by qi deficiency causing blood stasis and phlegm-heat stagnation | |
| CN105902927A (en) | Multifunctional health care traditional Chinese medicine formula | |
| CN103505607A (en) | Traditional Chinese medicine composition used for treating aplastic anemia | |
| CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
| CN102309653A (en) | Traditional Chinese medicine (TCM) prescription for treating advanced menstruation (blood deficiency) | |
| CN102309601A (en) | Traditional Chinese medicine (TCM) prescription for treating chloasma | |
| CN103127351B (en) | Traditional Chinese medicine for treating premature menstruation | |
| CN102078406A (en) | Traditional Chinese medicine for treating insomnia | |
| CN103610796A (en) | Traditional Chinese medicinal composition for treating exfoliative inflammation of lips | |
| CN104644857A (en) | Traditional Chinese medicine formula for treating acnes | |
| CN103550679A (en) | Traditional Chinese medicine formula for treatment of lithangiuria | |
| CN104666847A (en) | Traditional Chinese medicine decoction for treating allergic asthma | |
| CN104707089A (en) | Coronary heart disease treating traditional Chinese medicine formula | |
| CN102949642A (en) | Traditional Chinese medicine composition for treating pneumonia and preparation method thereof | |
| CN104107328A (en) | Traditional Chinese medicine dry paste for treatment of stomach troubles | |
| CN103800859A (en) | Traditional Chinese medicinal composition for treating stomach cold | |
| CN103381248A (en) | Traditional Chinese medicine composition for treating emphysema and preparation method thereof | |
| CN101143178A (en) | Traditional Chinese medicine for treating advanced esophageal cancer | |
| CN105395883A (en) | Traditional Chinese medicine for curing anemia | |
| CN101366911B (en) | Traditional Chinese medicine for treating alopecia | |
| CN105963601B (en) | It is a kind of to treat phthisical Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140115 |
|
| RJ01 | Rejection of invention patent application after publication |